This NDC is on FDA's drug shortage list (posted Oct 31, 2017)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
MORPHINE 10 MG/ML CARPUJECT is a generic product labeled by Hospira Inc., priced at $1.5952 per ML under NDC 00409189301. Its NADAC has been published 179 times since Mar 18, 2015.
FDA first approved this application on Nov 14, 2011. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hospira Inc.NDC
00409189301
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
4/23/2025
Active Ingredients
MORPHINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA202515FDA Approved
11/14/2011
TE Code
AP
On Market Since
8/20/2012
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE 10 MG/ML CARPUJECT has been published 179 times since Mar 18, 2015, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5952 per ML |
|---|---|
| All-time high | $1.8422 (Jun 14, 2017) |
| All-time low | $1.5952 (Feb 19, 2025) |
| 52-week high | $1.5952 |
| 52-week low | $1.5952 |
| Median price | $1.7264 |
| Average price | $1.7245 |
| Largest weekly change | -13.4% (Feb 19, 2025) |
| Weeks tracked | 179 |
| Tracking since | Mar 18, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
-13.4%
5Y
-13.4%
All
-10.6%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MORPHINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MORPHINE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE 10 MG/ML CARPUJECT?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE 10 MG/ML CARPUJECT, manufactured by Hospira Inc., is $1.5952 per ML (NDC 00409189301), effective Apr 15, 2026.
How has the price of MORPHINE 10 MG/ML CARPUJECT changed over time?
Over the history we have for it, the NADAC for MORPHINE 10 MG/ML CARPUJECT has declined 10.6%. It has been tracked across 179 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for MORPHINE 10 MG/ML CARPUJECT?
Since Mar 18, 2015, the NADAC for MORPHINE 10 MG/ML CARPUJECT has ranged from a low of $1.5952 (Feb 19, 2025) to a high of $1.8422 (Jun 14, 2017), with a median of $1.7264 per ML.
Are there cheaper alternatives to MORPHINE 10 MG/ML CARPUJECT?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE 10 MG/ML CARPUJECT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE 10 MG/ML CARPUJECT?
MORPHINE 10 MG/ML CARPUJECT (NDC 00409189301) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is MORPHINE 10 MG/ML CARPUJECT in shortage?
Yes — NDC 00409189301 is currently listed in FDA's drug shortage database (posted Oct 31, 2017). Reported reason: Discontinuation of the manufacture of the drug.